CSS LLC’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-59,300
Closed -$138K 1346
2022
Q1
$138K Buy
+59,300
New +$185K 0.01% 899
2021
Q1
Sell
-200
Closed -$1K 1116
2020
Q4
$1K Sell
200
-33,300
-99% -$267K ﹤0.01% 801
2020
Q3
$372K Buy
33,500
+30,100
+885% +$275K 0.02% 468
2020
Q2
$21K Buy
+3,400
New +$13K ﹤0.01% 608

Other funds holding SRNE

CSS LLC's SRNE Position: Q2 2022 in Review

CSS LLC sold out of Sorrento Therapeutics, Inc. (SRNE) in Q2 2022, closing a stake of 7,900 shares — an estimated $18K sold.

CSS LLC first reported a position in SRNE in Q2 2020 and held it in 4 quarters. The position peaked at $142K in Q3 2020. 229 funds tracked by Wall St. Rank hold SRNE as of Q2 2022.

  • CSS LLC reported no remaining Sorrento Therapeutics, Inc. position as of Q2 2022 after selling out during the quarter.
  • CSS LLC sold 7,900 Sorrento Therapeutics, Inc. shares in Q2 2022, an estimated $18K.
  • CSS LLC first reported a position in Sorrento Therapeutics, Inc. in Q2 2020 and held it in 4 quarters.
  • CSS LLC's Sorrento Therapeutics, Inc. position peaked at $142K in Q3 2020.
  • 229 funds tracked by Wall St. Rank held Sorrento Therapeutics, Inc. as of Q2 2022.

Based on CSS LLC's 13F filing for Q2 2022, filed 15 Aug 2022.